Cardinal Health, Inc. (CAH) is a Medical - Distribution company in the Healthcare sector, currently trading at $214.95. It has a SharesGrow Score of 56/100, indicating a above average investment profile with 1 out of 7 criteria passed.
SharesGrow calculates the intrinsic value of CAH = $293.86 (+36.7% from the current price, the stock appears undervalued). Analyst consensus target is CAH = $252 (+17.4% upside).
Valuation: CAH trades at a trailing Price-to-Earnings (P/E) of 30.6 (S&P 500 average ~25) with a forward Price/Earnings-to-Growth (PEG) of 2.46.
Financials: revenue is $222.6B, +7.3%/yr average growth. Net income is $1.6B, growing at +145.9%/yr. Net profit margin is 0.7% (thin). Gross margin is 3.7% (+0.1 pp trend).
Balance sheet: total debt is $9.3B with negative equity of -$2.8B — this means total liabilities exceed total assets. This is a warning sign that may indicate accumulated losses, aggressive share buybacks, heavy debt financing, or aggressive dividend payouts. Companies like McDonald's and Starbucks also carry negative equity due to buybacks and dividends, but investors should assess whether the business generates sufficient cash flow to service its debt and sustain payouts. Current ratio is 0.94 (tight liquidity). Debt-to-assets is 17.6%. Total assets: $53.1B.
Analyst outlook: 18 / 33 analysts rate CAH as buy (55%) — moderate consensus.
SharesGrow 7-Criteria breakdown: Value 45/100 (Partial), Growth 83/100 (Pass), Past 75/100 (Partial), Health 50/100 (Partial), Moat 49/100 (Partial), Future 58/100 (Partial), Income 30/100 (Fail).
